Download MendeleyDiscovery of novel cyanamide-based inhibitors of cathepsin C.
Laine, D., Palovich, M., McCleland, B., Petitjean, E., Delhom, I., Xie, H., Deng, J., Lin, G., Davis, R., Jolit, A., Nevins, N., Zhao, B., Villa, J., Schneck, J., McDevitt, P., Midgett, R., Kmett, C., Umbrecht, S., Peck, B., Davis, A.B., Bettoun, D.(2011) ACS Med Chem Lett 2: 142-147
- PubMed: 24900293
- DOI: https://doi.org/10.1021/ml100212k
- Primary Citation of Related Structures:
3PDF - PubMed Abstract:
The discovery of potent and selective cyanamide-based inhibitors of the cysteine protease cathepsin C is detailed. Optimization of the template with regard to plasma stability led to the identification of compound 17, a potent cathepsin C inhibitor with excellent selectivity over other cathepsins and potent in vivo activity in a cigarette smoke mouse model.
Organizational Affiliation:
GlaxoSmithKline, Respiratory CEDD, 709 Swedeland Road, P.O. Box 1539, King of Prussia, Pennsylvania 19406-0939, United States.
